— Know what they know.
Not Investment Advice

ZYBT NASDAQ

Zhengye Biotechnology Holding Limited
1W: -6.9% 1M: -25.1% 3M: +75.3% YTD: +8.0% 1Y: -49.8%
$1.24
-0.02 (-1.59%)
 
Weekly Expected Move ±7.6%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 35 · $58.8M mcap · 4M float · 87.29% daily turnover · Short 56% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$58.8M
52W Range0.6155-8.01
Volume15,913
Avg Volume3,864,764
Beta-2.53
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSonglin Song
Employees269
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2025-01-07
No.1 Lianmeng Road
Jilin, JI 132101
CN
86 432 6304 7008
About Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.

Recent Insider Trades

NameTypeSharesPriceDate
Han Zhenfa 0 — 2026-06-25
Han Zhenfa 0 — 2026-06-25
Han Zhenfa 0 — 2026-06-25
Cheng Yuhong (nmn) 0 — 2026-06-25
Song Songlin 0 — 2026-06-25

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms